Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy

Condition(s) studied

Investigational drug(s) / intervention(s)

Diagnosis of ACM: Definite ACM diagnosis is based on the consensus-based 2010 Task Force Criteria, which include major and minor criteria in six categories (depolarization and repolarization abnormalities, arrhythmia, imaging, histology, and family history/genetics). Among these, repolarization abnormalities (T-wave inversion in the precordial leads) constitute the most commonly observed, followed by frequent premature ventricular complex. With regards to imaging techniques, both the presence of wall motion abnormalities and an abnormal ventricular volume or function are required for fulfilment. Definite ACM consists of two major criteria or one major and two minor criteria or four minor criteria from different categories. Borderline ACM consists of one major and one minor criterion or three minor criteria from different categories.

Study summary

This study will include patients diagnosed with Arrhythmogenic cardiomyopathy (ACM) in the First Affiliated Hospital of Xi 'an Jiaotong University and other centers, and collect clinical data and biological samples of patients with different ACM phenotypes. Through the establishment of disease cohort and long-term follow-up, to explore the disease characteristics, development law, clinical characteristics, natural course of disease and long-term prognosis of ACM.

Eligibility

Primary outcome measure(s)

• Change in the incidence of mortality rate — At diagnosis, before discharge (about 7 days), 1, 3, 6, 9 month, 1, 2, 3 year.
  The survival status will be obtained from the medical records and phone calls to patients or their family members.

Trial sites (1)

More First Affiliated Hospital Xi'an Jiaotong University trials in China

Other trials for the same condition